Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits

Arnold J.J., Choksi Y., Chen X., Shimazaki A., Hatten J., Toone E.J., Epstein D.L., Challa P.

2009
Journal of Ocular Pharmacology and Therapeutics

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Department of Ophthalmology, Duke University School of Medicine, Duke University, Durham, NC, United States; Department of Chemistry, Duke University School of Medicine, Duke University, Durham, NC, United States; Santen Pharmaceutical Co Ltd., Tokyo, Japan; Department of Pharmaceutical, Social, and Administrative Sciences, Samford University McWhorter School of Pharmacy, Birmingham, AL, United States; Duke Eye Center, Box 3802 DUMC, Durham, NC 27710, United States

Related Publications

Benefit of omidenepag isopropyl ophthalmic solution in treatment persistence in Japanese patients with glaucoma

Kashiwagi K., Nakano T., Nakazawa T., Fuwa M., Otsuka N., Shii D., Miyahara R.

Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow Dysfunction

Sharif NA, Ohia SE, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, Njie-Mbye YF

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.

View all Glaucoma publications